WO2020204973A1 - Urea biosensors and stabilization of urea biosensors at room temperature - Google Patents

Urea biosensors and stabilization of urea biosensors at room temperature Download PDF

Info

Publication number
WO2020204973A1
WO2020204973A1 PCT/US2019/035153 US2019035153W WO2020204973A1 WO 2020204973 A1 WO2020204973 A1 WO 2020204973A1 US 2019035153 W US2019035153 W US 2019035153W WO 2020204973 A1 WO2020204973 A1 WO 2020204973A1
Authority
WO
WIPO (PCT)
Prior art keywords
biosensor
urea
electrode
enzyme
urease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2019/035153
Other languages
English (en)
French (fr)
Inventor
Clarke Xu
Prasad Pamidi
Hyoungsik Yim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Werfen North America
Original Assignee
Instrumentation Laboratory Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instrumentation Laboratory Co filed Critical Instrumentation Laboratory Co
Priority to EP19739734.2A priority Critical patent/EP3947711B1/en
Priority to DK19739734.2T priority patent/DK3947711T3/da
Priority to CN201980043624.2A priority patent/CN112534058B/zh
Priority to KR1020207037318A priority patent/KR102519406B1/ko
Priority to CA3105191A priority patent/CA3105191A1/en
Priority to JP2020570928A priority patent/JP7135121B2/ja
Publication of WO2020204973A1 publication Critical patent/WO2020204973A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/28—Electrolytic cell components
    • G01N27/30—Electrodes, e.g. test electrodes; Half-cells
    • G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
    • G01N27/3275—Sensing specific biomolecules, e.g. nucleic acid strands, based on an electrode surface reaction
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/28—Electrolytic cell components
    • G01N27/30—Electrodes, e.g. test electrodes; Half-cells
    • G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
    • G01N27/3271—Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D67/00—Processes specially adapted for manufacturing semi-permeable membranes for separation processes or apparatus
    • B01D67/0002—Organic membrane manufacture
    • B01D67/0009—Organic membrane manufacture by phase separation, sol-gel transition, evaporation or solvent quenching
    • B01D67/00091—Organic membrane manufacture by phase separation, sol-gel transition, evaporation or solvent quenching by evaporation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D67/00—Processes specially adapted for manufacturing semi-permeable membranes for separation processes or apparatus
    • B01D67/0002—Organic membrane manufacture
    • B01D67/0009—Organic membrane manufacture by phase separation, sol-gel transition, evaporation or solvent quenching
    • B01D67/0011—Casting solutions therefor
    • B01D67/00111—Polymer pretreatment in the casting solutions
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D67/00—Processes specially adapted for manufacturing semi-permeable membranes for separation processes or apparatus
    • B01D67/0002—Organic membrane manufacture
    • B01D67/0009—Organic membrane manufacture by phase separation, sol-gel transition, evaporation or solvent quenching
    • B01D67/0013—Casting processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D69/00—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor
    • B01D69/10—Supported membranes; Membrane supports
    • B01D69/107—Organic support material
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D69/00—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor
    • B01D69/12—Composite membranes; Ultra-thin membranes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D69/00—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor
    • B01D69/12—Composite membranes; Ultra-thin membranes
    • B01D69/1213—Laminated layers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D69/00—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor
    • B01D69/14—Dynamic membranes
    • B01D69/141—Heterogeneous membranes, e.g. containing dispersed material; Mixed matrix membranes
    • B01D69/142—Heterogeneous membranes, e.g. containing dispersed material; Mixed matrix membranes with "carriers"
    • B01D69/144—Heterogeneous membranes, e.g. containing dispersed material; Mixed matrix membranes with "carriers" containing embedded or bound biomolecules
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D71/00—Semi-permeable membranes for separation processes or apparatus characterised by the material; Manufacturing processes specially adapted therefor
    • B01D71/06—Organic material
    • B01D71/54—Polyureas; Polyurethanes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/001—Enzyme electrodes
    • C12Q1/002—Electrode membranes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/001—Enzyme electrodes
    • C12Q1/002—Electrode membranes
    • C12Q1/003—Functionalisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/001—Enzyme electrodes
    • C12Q1/005—Enzyme electrodes involving specific analytes or enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/54—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving glucose or galactose
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/28—Electrolytic cell components
    • G01N27/30—Electrodes, e.g. test electrodes; Half-cells
    • G01N27/308—Electrodes, e.g. test electrodes; Half-cells at least partially made of carbon
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/28—Electrolytic cell components
    • G01N27/30—Electrodes, e.g. test electrodes; Half-cells
    • G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
    • G01N27/3271—Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood
    • G01N27/3272—Test elements therefor, i.e. disposable laminated substrates with electrodes, reagent and channels
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/28—Electrolytic cell components
    • G01N27/30—Electrodes, e.g. test electrodes; Half-cells
    • G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
    • G01N27/3275—Sensing specific biomolecules, e.g. nucleic acid strands, based on an electrode surface reaction
    • G01N27/3276—Sensing specific biomolecules, e.g. nucleic acid strands, based on an electrode surface reaction being a hybridisation with immobilised receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/28—Electrolytic cell components
    • G01N27/30—Electrodes, e.g. test electrodes; Half-cells
    • G01N27/333—Ion-selective electrodes or membranes
    • G01N27/3335—Ion-selective electrodes or membranes the membrane containing at least one organic component
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/70—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving creatine or creatinine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06F—ELECTRIC DIGITAL DATA PROCESSING
    • G06F17/00—Digital computing or data processing equipment or methods, specially adapted for specific functions
    • G06F17/10—Complex mathematical operations
    • G06F17/18—Complex mathematical operations for evaluating statistical data, e.g. average values, frequency distributions, probability functions, regression analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/30—Microarray design
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2323/00—Details relating to membrane preparation
    • B01D2323/12—Specific ratios of components used
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2325/00—Details relating to properties of membranes
    • B01D2325/34—Molecular weight or degree of polymerisation
    • B01D2325/341—At least two polymers of same structure but different molecular weight
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/58—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving urea or urease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/28—Electrolytic cell components
    • G01N27/30—Electrodes, e.g. test electrodes; Half-cells
    • G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
    • G01N27/3271—Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood
    • G01N27/3274—Corrective measures, e.g. error detection, compensation for temperature or hematocrit, calibration
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/28—Electrolytic cell components
    • G01N27/30—Electrodes, e.g. test electrodes; Half-cells
    • G01N27/333—Ion-selective electrodes or membranes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
    • G01N33/5438—Electrodes
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06F—ELECTRIC DIGITAL DATA PROCESSING
    • G06F30/00—Computer-aided design [CAD]
    • G06F30/30—Circuit design
    • G06F30/32—Circuit design at the digital level
    • G06F30/33—Design verification, e.g. functional simulation or model checking
    • G06F30/3308—Design verification, e.g. functional simulation or model checking using simulation
    • G06F30/331—Design verification, e.g. functional simulation or model checking using simulation with hardware acceleration, e.g. by using field programmable gate array [FPGA] or emulation

Definitions

  • Figure 3 A is a graphic illustration of measured high urea concentration (95 mg/dL) versus cartridge age of twelve urea biosensors after short sensor shelf-life of two weeks and up to 3 week use-life; Daily urea concentration measurement in high urea sample (95 mg/dL) over 3 -week use life;
  • Figure 3B is a graphic illustration of measured high urea concentration (95 mg/dL) versus cartridge age of twelve urea biosensors stored at ambient temperature over 5 months and up to 3 week use-life. Daily urea concentration measurement in high urea sample (95 mg/dL) over 3-week use life.
  • the inventions described below are directed to a device and related method for enhancing enzyme stability and extending the shelf-life and use-life of urea biosensors useful in clinical analyzers for in vitro diagnostics, point-of-care applications in particular.
  • the outer diffusion layer 165 controls the diffusion of the analyte into the enzyme layer 170 and protects the other components of the urea biosensor 150 from direct contact with the analytical sample in the channel 20.
  • the enzyme layer 170 may include at least one enzyme, or a mixture of several enzymes, proteins and stabilizers that react with a particular analyte, i.e., urea in the patient sample. If the analyte diffuses through the outer diffusional membrane 165 into the enzyme layer, it can react with the enzyme in the enzyme layer 170 to produce a chemical byproduct, in the case of urea, ammonium ions. An electrical potential is generated across the composite membrane 160 that depends on the concentration of the chemical byproduct that is proportional to the concentration of urea in the analytical sample.
  • PVC may be a constituent of the ammonium selective polymeric membrane 175.
  • the steps for making a stable disaccharide- treated urea sensor according to the invention include:
  • the steps include;
  • a urease enzyme in a polysaccharide solution such as a sucrose solution or alternatively a solution of trehalose, raffmose, or lactitol in concentrations (w/v) ranging from >0% to 2%, 2% to 25%, 2% to 20%, 5% to 15%, 10% to 15%, preferably, 10% solution
  • a polysaccharide solution such as a sucrose solution or alternatively a solution of trehalose, raffmose, or lactitol in concentrations (w/v) ranging from >0% to 2%, 2% to 25%, 2% to 20%, 5% to 15%, 10% to 15%, preferably, 10% solution
  • the steps include:
  • a urease enzyme solution in a polysaccharide solution such as a sucrose solution in water or alternatively a solution of trehalose, raffmose, or lactitol in concentrations (w/v) ranging from >0% 2% to 25%, 2% to 20%, 5% to 15%, 10% to 15%, preferably, 10% solution;
  • a solution for an ammonium selective polymer membrane is prepared in THF and contains, for example, 25-35 % PVC, 60-70 % DOS, 1-5 % nonactin, and 0-1 % KTpCIPB by weight.
  • Nonactin is an ionophore with specific selectivity towards ammonium.
  • Other reagents for example, monactin, dinactin, trinactin, tetranactin, narasin, benzocrown ethers, cyclic depsipeptides, and mixtures of the preceding can also be used for this purpose.
  • NPOE is another commonly used plasticizer.
  • KTpCIPB Lithyl tetrakis[4-chlorophenyl]borate
  • the polymer membrane can also include, for example, polyurethane, poly(tetrafluoroethylene), poly(methyl methacrylate), silicone rubber, and mixtures of above.
  • THF tetrahydrofuran
  • Cyclohexanone can also be used for this purpose.
  • the ammonium sensor is planar and formed by casting the ammonium selective polymer membrane solution made as described above on a Ag/AgCl metal electrode and an inner electrolyte layer to form an internal reference electrode which is embedded in a solid substrate, for example, but not limited to PVC.
  • the inner electrolyte layer is formed by casting the inner solution on the Ag/AgCl electrode surface.
  • the inner solution contains, for example, a 65% MES buffer, 1% sodium chloride, 1% ammonium chloride, and 33% HEC (percentages by weight) in water.
  • the enzymatic layer is formed by casting an enzyme solution on the outer surface of the ammonium-selective PVC membrane.
  • the enzyme solution includes an enzyme urease, enzyme stabilizer glutathione, inert proteins bovine serum albumin, cross-linking agent glutaraldehyde and solvents. Glutathione is used together with one or more inert proteins, e.g., bovine serum albumin, to stabilize the urease in the enzyme layer.
  • Cross-linking also secures the enzymatic layer to the underlying ion-selective polymeric layer.
  • the enzyme stabilizers are generally added to the solution containing the enzyme prior to the addition of the cross-linking agent to ensure the stabilizers are cross-linked together with the enzyme.
  • a typical enzyme solution was prepared containing 50 mg/mL urease, 20 mg/mL glutathione, 10 mg/mL bovine serum albumin, and 0.12% glutaraldehyde in 0.1 M phosphate buffer at a pH of 7.2, and the solution was applied to the top of the ammonium ion- selective PVC membrane.
  • Polyurethane (PU) is one of the polymers that has superior
  • hydrophilic medical grade polyurethane families selected to be optimized for this application are TecophlicTM and TecoflexTM from Lubrizol (Wickliffe, Ohio). These
  • the outer diffusional membrane of the urea biosensor in contact with the patient sample in various embodiments includes one or more distinct layers of identical or different polymers and/or identical or different co-polymers.
  • a typical outer diffusional membrane solution was prepared containing 0.12 g/ml polyurethane (Lubrizol, Wickliffe, Ohio) in THF. The outer diffusional membrane solution was applied over the enzyme layer to form the outer diffusional membrane.
  • NAFION® the following polymers can also be candidates for the outer diffusional membrane
  • poly(tetrafluoroethylene) ionomers) poly(tetrafluoroethylene) ionomers), poly-(2-hydroxymethyl methacrylate), polyvinyl chloride, polycarbonate, and cellulose acetate.
  • the urea sensor with composite membrane of inner layer - PVC layer - Enzyme layer - polyurethane layer is then immersed in a disaccharide solution, for example, a sucrose solution, in (w/v) concentrations ranging from ranging from >0% to 2%, 2% to 25%, 2% to 20%, 5% to 15%, 10% to 15%, preferably, 10% solution for at least 30 minutes to 24 hours, at least 30 minutes to 240 minutes, at least 30 minutes to 120 minutes, at least 30 minutes to 60 minutes, preferably at least 30 minutes.
  • the sucrose solution is buffered at biological pH of 7.4.
  • the sensor is dried at room temperature for 0.5 hours to 3 hours.
  • sucrose treatment is repeated multiple times followed by air drying each time.
  • the sensor is then stored at ambient temperature until use.
  • Figure 2A the use-life stability of each of the tested urea sensors at various applied experimental conditions when the drying time is fixed at 3 hours is provided.
  • Figure 2B illustrates the effect of the experimental conditions on urea measurement.
  • FIG. 2A The results shown in Figure 2A are readily summarized.
  • the condition applied with shorter delay time (2 days) and longer soak time (16 hours) in 10% sucrose solution provided the most stable performance over the use-life of the sensor and most consistent sensor- to-sensor performance.
  • the other two conditions provided better performance compared to the poorest performance of 7 day delay time/2 hour soak time but also exhibited inconsistency from sensor-to-sensor (7 days, 16 hours), or performance deterioration over the-use-life (2 days, 2 hours).
  • Figure 2B illustrates urea measurement and the favorable direction for all three sucrose treatment condition factors: shorter delay time, longer soak time and longer drying time.
  • Example 3 provides stability data at ambient temperature for urea sensors obtained from multiple production batches made according to the invention in a three week use- life stability and 5-month shelf life stability studies.
  • Figure 3 A graphically illustrates urea measured in twelve urea sensors selected from three batches of sucrose treated sensors and short shelf-life storage at ambient temperature of two weeks. Daily measurement of the high urea concentration (95 mg/dL) sample over the three week use-life at short sensor shelf-life showed stable use-life performance with consistent measured urea concentration of about 95 mg/dl.
  • Figure 3B graphically illustrates the results from another twelve urea sensors from three different batches of sucrose treated urea sensors.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Electrochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Theoretical Computer Science (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Data Mining & Analysis (AREA)
  • Dispersion Chemistry (AREA)
  • Computational Mathematics (AREA)
  • Pure & Applied Mathematics (AREA)
  • Mathematical Optimization (AREA)
  • Mathematical Physics (AREA)
  • Mathematical Analysis (AREA)
  • Evolutionary Biology (AREA)
PCT/US2019/035153 2019-04-05 2019-06-03 Urea biosensors and stabilization of urea biosensors at room temperature Ceased WO2020204973A1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
EP19739734.2A EP3947711B1 (en) 2019-04-05 2019-06-03 Room temperature stabilised urea biosensors
DK19739734.2T DK3947711T3 (da) 2019-04-05 2019-06-03 Urinstofbiosensorer, der er stabiliseret ved rumtemperatur
CN201980043624.2A CN112534058B (zh) 2019-04-05 2019-06-03 脲生物传感器和脲生物传感器在室温下的稳定化
KR1020207037318A KR102519406B1 (ko) 2019-04-05 2019-06-03 우레아 바이오센서 및 실온에서의 우레아 바이오센서의 안정화
CA3105191A CA3105191A1 (en) 2019-04-05 2019-06-03 Urea biosensors and stabilization of urea biosensors at room temperature
JP2020570928A JP7135121B2 (ja) 2019-04-05 2019-06-03 尿素バイオセンサ及び室温における尿素バイオセンサの安定化

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962830191P 2019-04-05 2019-04-05
US62/830,191 2019-04-05

Publications (1)

Publication Number Publication Date
WO2020204973A1 true WO2020204973A1 (en) 2020-10-08

Family

ID=67138031

Family Applications (5)

Application Number Title Priority Date Filing Date
PCT/US2019/035153 Ceased WO2020204973A1 (en) 2019-04-05 2019-06-03 Urea biosensors and stabilization of urea biosensors at room temperature
PCT/US2019/035157 Ceased WO2020204976A1 (en) 2019-04-05 2019-06-03 Outer membrane compositions for creatinine/creatine sensors
PCT/US2019/035155 Ceased WO2020204974A1 (en) 2019-04-05 2019-06-03 Compositions and methods for improved creatinine measurement accuracy and uses thereof
PCT/US2019/035152 Ceased WO2020204972A1 (en) 2019-04-05 2019-06-03 Improved calibration accuracy method for creatinine/creatine sensors
PCT/US2019/035156 Ceased WO2020204975A1 (en) 2019-04-05 2019-06-03 Multi-enzymatic biosensors and stabilization of multi-enzymatic biosensors at room temperature

Family Applications After (4)

Application Number Title Priority Date Filing Date
PCT/US2019/035157 Ceased WO2020204976A1 (en) 2019-04-05 2019-06-03 Outer membrane compositions for creatinine/creatine sensors
PCT/US2019/035155 Ceased WO2020204974A1 (en) 2019-04-05 2019-06-03 Compositions and methods for improved creatinine measurement accuracy and uses thereof
PCT/US2019/035152 Ceased WO2020204972A1 (en) 2019-04-05 2019-06-03 Improved calibration accuracy method for creatinine/creatine sensors
PCT/US2019/035156 Ceased WO2020204975A1 (en) 2019-04-05 2019-06-03 Multi-enzymatic biosensors and stabilization of multi-enzymatic biosensors at room temperature

Country Status (10)

Country Link
US (6) US11761921B2 (enExample)
EP (5) EP3946697B1 (enExample)
JP (6) JP7100162B2 (enExample)
KR (5) KR102574622B1 (enExample)
CN (6) CN112534058B (enExample)
AU (3) AU2019439424B2 (enExample)
CA (3) CA3104896A1 (enExample)
DK (2) DK3947708T3 (enExample)
ES (1) ES3038379T3 (enExample)
WO (5) WO2020204973A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7100162B2 (ja) * 2019-04-05 2022-07-12 インストゥルメンテーション ラボラトリー カンパニー 改善されたクレアチニン測定精度のための組成物及び方法並びにこれらの使用
US12139741B2 (en) 2019-10-25 2024-11-12 Instrumentation Laboratory Company Biocide compositions compatible with enzyme biosensors and methods of use thereof
US12298268B2 (en) * 2020-05-21 2025-05-13 Nova Biomedical Corporation Single-use disposable reference sensor
WO2023015187A1 (en) * 2021-08-03 2023-02-09 Polymer Technology Systems, Inc. Systems and methods for quantifying the specific activity of creatininase
EP4476537B1 (en) 2022-02-09 2025-10-29 Instrumentation Laboratory Company Sensor for measuring ionized magnesium
CN114705674B (zh) * 2022-05-10 2025-07-22 光景生物科技(苏州)有限公司 一种全血中肌酸和肌酐的定量检测方法
AU2024316973A1 (en) * 2023-07-31 2026-01-22 Abbott Diabetes Care Inc. Background interference mitigation for high sensitivity creatinine sensing
KR102800865B1 (ko) 2024-07-31 2025-05-07 전남대학교 산학협력단 신규한 크레아티닌 정량 장치

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003019171A1 (en) * 2001-08-24 2003-03-06 Sensor-Tech Limited Methods for producing highly sensitive potentiometric sensors
US20040256227A1 (en) 2003-02-11 2004-12-23 Jungwon Shin Electrochemical urea sensors and methods of making the same
US6960466B2 (en) 2001-05-31 2005-11-01 Instrumentation Laboratory Company Composite membrane containing a cross-linked enzyme matrix for a biosensor
WO2008028011A2 (en) * 2006-08-31 2008-03-06 Nanogen Inc. Compositions and methods for preserving permeation layers for use on active electronic matrix devices
WO2009082699A1 (en) * 2007-12-20 2009-07-02 I-Stat Corporation Compositions for forming immobiized biological layers for sensing

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5861459A (ja) * 1981-10-07 1983-04-12 Hitachi Ltd クレアチンとクレアチニンの分析装置
JPS6475000A (en) 1987-09-14 1989-03-20 Shimadzu Corp Method and equipment for analyzing creatinine
US5464747A (en) * 1993-10-29 1995-11-07 Boehringer Mannheim Corporation Oxidation-resistant muteins of β-galactosidase fragments
EP0944731B1 (en) * 1996-11-14 2006-01-18 Radiometer Medical ApS Enzyme sensor
DE69810194T2 (de) * 1997-06-03 2003-11-20 Matsushita Electric Industrial Co. Ltd., Osaka Cholesterinsensor
JP3635263B2 (ja) 2000-03-01 2005-04-06 ラジオメーター・メディカル・アクティーゼルスカブ 固体状態参照系を持つ電極デバイス
AT408662B (de) * 2000-05-16 2002-02-25 Hoffmann La Roche Creatinin-sensor
AT409040B (de) 2000-08-11 2002-05-27 Roche Diagnostics Gmbh Creatininsensor-kalibration
US6872297B2 (en) * 2001-05-31 2005-03-29 Instrumentation Laboratory Company Analytical instruments, biosensors and methods thereof
US6767441B1 (en) 2001-07-31 2004-07-27 Nova Biomedical Corporation Biosensor with peroxidase enzyme
ES2355333T3 (es) * 2001-08-22 2011-03-24 Instrumentation Laboratory Company Método y aparato para calibrar sensores .
US7285198B2 (en) 2004-02-23 2007-10-23 Mysticmd, Inc. Strip electrode with conductive nano tube printing
GB0227424D0 (en) * 2002-11-25 2002-12-31 Univ Warwick Coatings
EP1679508B1 (en) 2003-10-30 2010-07-21 Arkray, Inc. Biosensor and method for preparation thereof
DK1692522T3 (da) 2003-11-28 2012-04-02 Radiometer Medical Aps Referencevæske
US7699964B2 (en) * 2004-02-09 2010-04-20 Abbott Diabetes Care Inc. Membrane suitable for use in an analyte sensor, analyte sensor, and associated method
US7946984B2 (en) * 2004-07-13 2011-05-24 Dexcom, Inc. Transcutaneous analyte sensor
EP1885870A1 (en) 2005-05-17 2008-02-13 Radiometer Medical ApS Enzyme sensor including a water-containing spacer layer
CN102608176B (zh) 2005-05-17 2016-08-10 雷迪奥米特医学公司 用二价锰离子溶液稳定或再活化肌酸酐传感器的方法
WO2006122552A1 (en) 2005-05-17 2006-11-23 Radiometer Medical Aps Method of stabilising or reactivating a creatinine sensor with a solution of a divalent manganese ion
US7959791B2 (en) 2005-05-17 2011-06-14 Radiometer Medical Aps Enzyme sensor with a cover membrane layer covered by a hydrophilic polymer
KR100726963B1 (ko) * 2005-06-15 2007-06-14 김경훈 바이오센서용 우레아제 고정화막의 제조 방법
US7799195B2 (en) * 2005-09-02 2010-09-21 Vladislav Dolnik Neutral polysaccharide wall coating for electrophoretic separations in capillaries and microchannels
US8617366B2 (en) * 2005-12-12 2013-12-31 Nova Biomedical Corporation Disposable urea sensor and system for determining creatinine and urea nitrogen-to-creatinine ratio in a single device
US9556471B2 (en) * 2006-08-09 2017-01-31 Flir Detection, Inc. Enzyme containing liquid and delivery system for detection of analytes on surfaces
IES20070774A2 (en) 2007-10-24 2008-12-24 Nat Univ Ireland Maynooth Monitoring target endogenous species in the brain
WO2011037702A1 (en) 2009-09-24 2011-03-31 Fresenius Medical Care Holdings, Inc. Amperometric creatinine biosensor with immobilized enzyme-polymer composition and systems using same, and methods
US9233788B2 (en) 2010-01-22 2016-01-12 Bayer Healthcare Llc Biosensor desiccant system having enhanced measurement performance
JP2014153243A (ja) 2013-02-12 2014-08-25 Tanita Corp バイオセンサおよびこれを用いた測定方法
EP2972275B1 (en) 2013-03-14 2019-07-10 Instrumentation Laboratory Company Whole blood hemolysis sensor
US9487811B2 (en) * 2013-03-15 2016-11-08 Abbott Point Of Care Inc. Biosensor structures for improved point of care testing and methods of manufacture thereof
WO2016096725A1 (en) 2014-12-18 2016-06-23 Radiometer Medical Aps Method for calibrating a device for measuring the concentration of creatinine
WO2016096683A1 (en) 2014-12-18 2016-06-23 Radiometer Medical Calibration concept for amperometric creatinine sensor correcting for endogenous modulators
DK3234564T3 (da) 2014-12-18 2025-02-10 Radiometer Medical Aps Fremgangsmåde til kalibrering af en indretning til måling af koncentrationen af kreatinin
CN108291889B (zh) 2015-11-27 2021-03-12 雷迪奥米特医学公司 用于酶传感器的外层
JP7011906B2 (ja) 2017-08-25 2022-01-27 国立大学法人 筑波大学 クレアチニンセンサ
EP3676306B1 (en) 2017-08-28 2022-05-25 DSM IP Assets B.V. Synthetic membrane composition comprising polyurethane blend
JP7100162B2 (ja) 2019-04-05 2022-07-12 インストゥルメンテーション ラボラトリー カンパニー 改善されたクレアチニン測定精度のための組成物及び方法並びにこれらの使用

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6960466B2 (en) 2001-05-31 2005-11-01 Instrumentation Laboratory Company Composite membrane containing a cross-linked enzyme matrix for a biosensor
WO2003019171A1 (en) * 2001-08-24 2003-03-06 Sensor-Tech Limited Methods for producing highly sensitive potentiometric sensors
US20040256227A1 (en) 2003-02-11 2004-12-23 Jungwon Shin Electrochemical urea sensors and methods of making the same
EP1753872A1 (en) 2004-06-09 2007-02-21 Instrumentation Laboratory Company Electrochemical urea sensors and methods of making the same
WO2008028011A2 (en) * 2006-08-31 2008-03-06 Nanogen Inc. Compositions and methods for preserving permeation layers for use on active electronic matrix devices
WO2009082699A1 (en) * 2007-12-20 2009-07-02 I-Stat Corporation Compositions for forming immobiized biological layers for sensing

Also Published As

Publication number Publication date
CN112534059B (zh) 2025-01-07
ES3038379T3 (en) 2025-10-13
WO2020204975A1 (en) 2020-10-08
US12529673B2 (en) 2026-01-20
KR102519406B1 (ko) 2023-04-10
JP2021527224A (ja) 2021-10-11
EP3947711B1 (en) 2023-12-20
KR20210013625A (ko) 2021-02-04
US20220187234A1 (en) 2022-06-16
WO2020204972A1 (en) 2020-10-08
CN112424369A (zh) 2021-02-26
US20200319134A1 (en) 2020-10-08
CN112534058A (zh) 2021-03-19
KR20210014667A (ko) 2021-02-09
EP3947708B1 (en) 2024-02-14
JP7127159B2 (ja) 2022-08-29
US11327042B2 (en) 2022-05-10
DK3947708T3 (da) 2024-03-11
JP2021524587A (ja) 2021-09-13
US20200319136A1 (en) 2020-10-08
DK3947711T3 (da) 2024-01-15
AU2019439465A1 (en) 2021-05-20
CA3104896A1 (en) 2020-10-08
KR20210149577A (ko) 2021-12-09
CN112534058B (zh) 2024-12-27
KR102574622B1 (ko) 2023-09-06
CA3105013C (en) 2023-03-28
JP7100162B2 (ja) 2022-07-12
US11761921B2 (en) 2023-09-19
CA3105191A1 (en) 2020-10-08
CA3105013A1 (en) 2020-10-08
US20200319210A1 (en) 2020-10-08
EP3946697B1 (en) 2025-08-06
JP2021527194A (ja) 2021-10-11
EP3946697A1 (en) 2022-02-09
JP7015401B2 (ja) 2022-02-02
KR102937635B1 (ko) 2026-03-12
US20200318152A1 (en) 2020-10-08
CN112534059A (zh) 2021-03-19
EP3947709A1 (en) 2022-02-09
US20200319211A1 (en) 2020-10-08
JP7082691B2 (ja) 2022-06-08
CA3101513A1 (en) 2020-10-08
AU2019439424B2 (en) 2022-10-13
EP3946697C0 (en) 2025-08-06
KR20210013626A (ko) 2021-02-04
CN112638513A (zh) 2021-04-09
KR102480669B1 (ko) 2022-12-26
WO2020204976A1 (en) 2020-10-08
EP3947710A1 (en) 2022-02-09
CA3105011A1 (en) 2020-10-08
EP3947711A1 (en) 2022-02-09
KR102519408B1 (ko) 2023-04-10
US11460431B2 (en) 2022-10-04
AU2019440163A1 (en) 2021-01-07
US11293890B2 (en) 2022-04-05
JP2021528640A (ja) 2021-10-21
CN119776481A (zh) 2025-04-08
WO2020204974A1 (en) 2020-10-08
CN112513285A (zh) 2021-03-16
AU2019439465B2 (en) 2025-01-02
JP7135121B2 (ja) 2022-09-12
CN112513285B (zh) 2024-06-25
KR20210014666A (ko) 2021-02-09
JP2022068299A (ja) 2022-05-09
AU2019439424A1 (en) 2021-01-07
JP2021525888A (ja) 2021-09-27
AU2019440163B2 (en) 2022-01-27
EP3947708A1 (en) 2022-02-09

Similar Documents

Publication Publication Date Title
EP3947711B1 (en) Room temperature stabilised urea biosensors
AU2005254966B2 (en) Electrochemical urea sensors and methods of making the same
EP1456635B1 (en) Analytical instruments, biosensors and methods
CA2809149C (en) Analytical instruments and biosensors, and methods for increasing their accuracy and effective life
Chen et al. A biocompatible needle-type glucose sensor based on platinum-electroplated carbon electrode
US20100133101A1 (en) Cross-linked enzyme matrix and uses thereof
JPH0679003B2 (ja) 酵素/電極式中センサー
Palleschi et al. Ideal hydrogen peroxide-based glucose sensor
Rhemrev-Boom et al. On-line continuous monitoring of glucose or lactate by ultraslow microdialysis combined with a flow-through nanoliter biosensor based on poly (m-phenylenediamine) ultra-thin polymer membrane as enzyme electrode
Böhm et al. A flow-through amperometric sensor based on dialysis tubing and free enzyme reactors
EP1692522B1 (en) A reference solution
JP2528102B2 (ja) 2方向の拡散を行うグルコ−ス基質感応電極
Demirkiran et al. Immobilization of glucose oxidase in silica sol-gel film for application to biosensor and amperometric determination of glucose
CS241022B2 (cs) Molekulárně selektivní senzor a způsob jeho výroby

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19739734

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2020570928

Country of ref document: JP

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 3105191

Country of ref document: CA

Ref document number: 20207037318

Country of ref document: KR

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2019739734

Country of ref document: EP

Effective date: 20211105

WWG Wipo information: grant in national office

Ref document number: 201980043624.2

Country of ref document: CN